Stock Information
Enliven Therapeutics Inc (ELVN)
Ticker Symbol: ELVN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,758.70 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.8457
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -24.88%
Latest News
-
Enliven Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Tue, Mar 3, 2026 9:05 PM
-
Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Wed, Feb 25, 2026 9:05 PM
Key Financials
Financial data not available
